Relative Expression of 1,25-Dihydroxyvitamin D3 Receptor,Vitamin D 1α-Hydroxylase,Vitamin D 24-Hydroxylase,and Vitamin D 25-Hydroxylase in Endometriosis and Gynecologic Cancers
Restricted accessResearch articleFirst published online July, 2007
Relative Expression of 1,25-Dihydroxyvitamin D3 Receptor,Vitamin D 1α-Hydroxylase,Vitamin D 24-Hydroxylase,and Vitamin D 25-Hydroxylase in Endometriosis and Gynecologic Cancers
The authors demonstrate expression of the vitamin D receptor (VDR) and its hydroxylases in the endometrium and ovaries of women with and without endometriosis and endometrial or ovarian cancer. Immunohistochemistry showed strong staining of the VDR in endometriosis and endometrial cancer, with the most intense staining in epithelial cells. The VDR mRNA was significantly increased in patients with endometrial and ovarian cancer compared to the control group. There was a significantly higher 1α-hydroxylase expression in the endometrium of patients with endometriosis compared to healthy controls. The observed differences in VDR and 1α -hydroxylase mRNA levels were maintained at the protein level. The authors found no differences in 25-OH vitamin D levels between the serum of patients with endometriosis (25.7 ± 2.1 ng/mL, n = 46) and healthy controls (22.6 ± 2.0 ng/mL, n = 33, P = .31). They hypothesize that vitamin D might influence the local activity of immune cells and cytokines thought to play important pathogenic roles in the development and maintenance of endometriosis.
Guyton KZ, Kensler TW, Posner GHVitamin D and vitamin D analogs as cancer chemopreventive agents. Nutr Rev.2003; 61:227-238.
2.
Ravid A., Koren R.The role of reactive oxygen species in the anticancer activity of vitamin D. Recent Results Cancer Res.2003;164:357-367.
3.
Koeffler HP, Aslanian N., O'Kelly J.Vitamin D (2) analog (Paricalcitol; Zemplar) for treatment of myelodysplastic syndrome. Leuk Res.2005;29:1259-1262.
4.
Holick MFVitamin D: a millennium perspective. J Cell Biochem.2003;88:296-307.
5.
Zehnder D., Bland R., Hughes SVAnalysis of the tissue distribution of 1α-hydroxylase identifies novel extra-renal sites for the synthesis of 1, 25-dihydroxyvitamin D3. J Endocrinol.2000:164(suppl):P1.
6.
Berger U., Wilson P., McClelland RA, Colston K., Haussler MR, Pike JWImmunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues. J Clin Endocrinol Metab.1988 ;67:607-613.
7.
Trump DL, Hershberger PA, Bernardi RJ, et al. Anti-tumor activity of calcitriol: pre-clinical and clinical studies. J Steroid Biochem Mol Biol. 2004;89-90:519-526.
8.
Missmer SA, Cramer DWEpidemiology of endometriosis. In: Olive DL , ed. Endometriosis in Clinical Practice. London, UK: Taylor & Francis; 2005:49-60.
9.
Varma R., Rollason T., Gupta JK, Maher EREndometriosis and the neoplastic process. Reproduction. 2004 ;127:293-304.
10.
Donnez J., Squifflet J., Pirard C., Jadoul P.,Wyns C., Smets M.The efficacy of medical and surgical treatment of endometriosis-associated infertility and pelvic pain. Gynecol Obstet Invest. 2002;54(suppl 1):2-7.
11.
Oral E., Ilvan S.,Tustas E., et al. Prevalence of endometriosis in malignant epithelial ovary tumours . Eur J Obstet Gynecol Reprod Biol.2003;109:97-101.
12.
Malloy PJ, Feldman D.Vitamin D resistance. Am J Med.1999 ;106:355-370.
13.
Hewison M., Zehnder D., Bland R., Stewart PM1alpha-hydroxylase and the action of vitamin D. J Mol Endocrinol.2000;25:141-148.
14.
Haussler M., Mangelsdorf DJ, Komm BS, et al. Molecular biology of the vitamin D hormone. Recent Prog Horm Research. 1988;44:263-305.
15.
Mangelsdorf DJ ,Thummel C., Beato M., et al.The nuclear receptor superfamily: the second decade. Cell. 1995 ;83:835-839.
16.
Kliewer SA, Umesono K., Mangelsdorf DJ, Evans RMRetinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature. 1992;355:446-449.
17.
Jones G., Strugnell SA, DeLuca HFCurrent understanding of the molecular actions of vitamin D. Physiol Rev.1998;78: 1193-1231.
18.
Porojnicu AC , Robsahm TE, Dahlback A., et al. Seasonal and geographical variations in lung cancer prognosis in Norway. Does vitamin D from the sun play a role?Lung Cancer. 2007 ;55:263-270.
19.
Yabushita H. , Hirata M., Noguchi M., Nakanishi M.Vitamin D receptor in endometrial carcinoma and the differentiation-inducing effect of 1, 25-dihydroxyvitamin D3 on endometrial carcinoma cell lines. J Obstet Gynaecol Res. 1996;22:529-539.
20.
Cross HS, Bises G., Lechner D., Manhardt T., Kallay E.The Vitamin D endocrine system of the gut—its possible role in colorectal cancer prevention. J Steroid Biochem Mol Biol . 2005;97:121-128.
21.
Villena-Heinsen C., Meyberg R., Axt-Fliedner R., Reitnauer K., Reichrath J., Friedrich M.Immunohistochemical analysis of 1,25-dihydroxyvitamin-D3-receptors, estrogen and progesterone receptors and Ki-67 in ovarian carcinoma. Anticancer Res.2002;22:2261-2267.
22.
Saunders DE , Christensen C., Lawrence WD, et al. Receptors for 1,25-dihydroxyvitamin D3 in gynecologic neoplasms. Gynecol Oncol.1992;44:131-136.
23.
Friedrich M. , Rafi L., Mitschele T., Tilgen W., Schmidt W., Reichrath J.Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer . Recent Results Cancer Res.2003;164:239-246.
24.
Ahonen MH, Zhuang YH, Aine R., Ylikomi T., Tuohimaa P.Androgen receptor and vitamin D receptor in human ovarian cancer: growth stimulation and inhibition by ligands. Int J Cancer . 2000 ;86:40-46.
25.
Anderson MG , Nakane M., Ruan X., Kroeger P., Wu-Wong JRExpression of VDR and CYP24A1 mRNA in human tumors. Cancer Chemother Pharmacol.2006;57:234-240.
26.
Feng J., Junying B., Pengfei L., Santo VN,Wenlong B.Induction of ovarian cancer cell apoptosis by 1,25-dihydroxyvitamin D3 through the down-regulation of telomerase. J Biol Chem.2004;279:53213-53221.
27.
Pengfei L., Chunrong L., Xiuhua Z., Xiaohong Z., Santo VN, Wenlong B.p27Kip1 stabilization and G1 arrest by 1,25-dihydroxyvitamin D3 in ovarian cancer cells mediated through down-regulation of cyclin e/cyclin-dependent kinase 2 and Skp1-Cullin-F-box protein/skp2 ubiquitin ligase. J Biol Chem.2004;279:25260-25267.
28.
Armitage EL , Aldhous MC, Anderson N., et al. Incidence of juvenile-onset Crohn's disease in Scotland: association with northern latitude and affluence. Gastroenterology. 2004;127: 1051-1057.
29.
Hernan MA, Olek MJ, Ascherio A.Geographic variation of MC incidence in two prospective studies of US women . Neurology. 1999;51:1711-1718.
30.
Rostand SGUltraviolet light may contribute to geographic and racial blood pressure differences . Hypertension. 1979;30: 150-156.
Garland FC, Garland CF, Gorham ED,Young JFGeographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med.1990;19:614-622.
33.
Ahonen MH, Tenkanen L., Teppo L., Hakama M., Tuohimaa P.Prostate cancer risk and pre-diagnostic serum 25-hydroxyvitamin D levels (Finland) . Cancer Causes Control. 2000;11:847-852.
34.
Ferrero S., Gillott DJ,Anserini P., et al.Vitamin D binding protein in endometriosis. J Soc Gynecol Investig. 2005;12:272-277.
35.
Jackson LW, Schisterman EF, Dey-Rao R, Browne R, Armstrong D. Oxidative stress and endometriosis . Hum Reprod. 2005;20:2014-2020.
36.
Agarwal A., Gupta S., Sharma RKRole of oxidative stress in female reproduction. Reprod BiolEndocrinol.2005;3:28.
37.
Vienonen A. , Miettinen S., Blauer M., et al. Expression of nuclear receptors and cofactors in human endometrium and myometrium. J Soc Gynecol Investig. 2004;11:61-62.
38.
Evans KN, Bulmer JN, Kilby MD, Hewison M.Vitamin D and placental-decidual function. J Soc Gynecol Investig . 2004; 11:263-271.
39.
Vigano P., Lattuada D., Mangioni S., et al. Cycling and early pregnant endometrium as a site of regulated expression of the vitamin D system. J Mol Endocrinol.2006;36:415-424.
40.
Taverna MJ, Selam JL, Slama G.Association between a protein polymorphism in the start codon of the vitamin D receptor gene and severe diabetic retinopathy in C-peptide-negative type 1 diabetes. J Clin Endocrinol Metab.2005;90:4803-4808.
41.
Agic A., Xu H., Finas D., Banz C., Diedrich K., Hornung D.Is endometriosis associated with systemic sublinical inflammation?Gynecol Obstet Invest. 2006;62:139-147.
